Drug Trial Radar · NCT06846554
A Trial of "APL-9796'' in Adults With Pulmonary Hypertension
Last checked: Nov 19, 2026Latest source record: May 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
48
Planned (sponsor's estimate)
Start
Apr 9, 2025
Primary completion
Aug 30, 2027
Study completion Sep 30, 2027
Sponsor
- Lead sponsor
- Apollo Therapeutics LtdIndustry
- Sponsor type
- Industry
- First posted
- Feb 26, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The AP13CP02 study is a phase 2, open-label, dose escalation trial to determine how safe and tolerable multiple subcutaneous (SC) injections of APL-9796 are for patients with PH. The study will also assess how effective APL-9796 could be for treating patients with PH and whether the body produces antibodies working against APL-9796. The trial will be conducted in two parts: * Part A: Up to 36 adults with WHO Group 1 Pulmonary arterial hypertension (PAH). * Part B (optional): Up to 12 adults with WHO Group 3 - PH associated with ILD (PH-ILD).
Conditions
- Pulmonary Arterial Hypertension
Interventions
APL-9796Drug
3 Cohorts are planned in Part A.
APL-9796Drug
The decision to initiate optional Part B in WHO Group 3 PH-ILD participants will be made by the Safety Review Committee (SRC).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]Time frame: Through study completion (approximately 2 years)
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Royal United Hospital Bath
Bath, United Kingdom · Recruiting
Royal Papworth Hospital
Cambridge, United Kingdom · Recruiting
Golden Jubilee Hospital
Clydebank, United Kingdom · Recruiting
Royal Brompton Hospital
London, United Kingdom · Recruiting
Sheffield Teaching Hospitals
Sheffield, United Kingdom · Recruiting
Hammersmith/Imperial Hospital
London, London, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.